翰森制药(03692)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

03692 翰森制药

交易中 03-10 09:57:30

34.820

+1.100

+3.26%

最高34.880	最低33.640	成交量165.04万
今开34.200	昨收33.720	日振幅3.68%
总市值2,108亿	流通市值2,108亿	总股本60.55亿
成交额5,694万	换手率0.03%	流通股本60.55亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"03692","market":"HK","secType":"STK","nameCN":"翰森制药","latestPrice":34.82,"timestamp":1773107821902,"preClose":33.72,"halted":0,"volume":1650359,"delay":0,"changeRate":0.03262158956109138,"floatShares":6055000000,"shares":6055000000,"eps":0.737226,"marketStatus":"交易中","change":1.1,"latestTime":"03-10 09:57:30","open":34.2,"high":34.88,"low":33.64,"amount":56943683,"amplitude":0.036773,"askPrice":34.82,"askSize":26000,"bidPrice":34.8,"bidSize":12000,"shortable":3,"etf":0,"ttmEps":0.87991,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1773115200000},"marketStatusCode":2,"adr":0,"listingDate":1560441600000,"exchange":"SEHK","adjPreClose":33.72,"dividendRate":0.010537,"openAndCloseTimeList":[[1773106200000,1773115200000],[1773118800000,1773129600000]],"volumeRatio":1.814069,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03692","defaultTab":"news","newsList":[{"id":"2617576788","title":"翰森制药，阿美替尼新适应症申报上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2617576788","media":"药圈大门","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617576788?lang=zh_cn&edition=full","pubTime":"2026-03-05 18:35","pubTimestamp":1772706916,"startTime":"0","endTime":"0","summary":"3月5日，CDE 官网显示，翰森制药阿美替尼新适应症申报上市。早在2020年3月，阿美替尼就首次获批上市，同年通过谈判进入国家医保目录，目前在国内已经拥有5项获批适应症。基于I期的积极结果，翰森制药在2023年启动了一项III期多中心临床研究，对比达麦利替尼联合阿美替尼与含铂双药化疗的疗效和安全性。阿美替尼作为翰森制药的核心产品之一，此次新适应症的申报如果顺利获批，将进一步扩大其覆盖的患者人群。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305193010a6a685d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305193010a6a685d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1583","03692","BK1589"],"gpt_icon":0},{"id":"2617762045","title":"每日卖空追踪 | 翰森制药 03月05日卖空量成交94.2万股，卖空比例为9.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617762045","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617762045?lang=zh_cn&edition=full","pubTime":"2026-03-05 16:30","pubTimestamp":1772699436,"startTime":"0","endTime":"0","summary":"翰森制药北京时间03月05日，涨1.56%，卖空量成交94.2万股，较上一交易日减少72.85%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163507a6a5da47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163507a6a5da47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1589","03692","BK1583"],"gpt_icon":0},{"id":"2617576780","title":"翰森制药盘中异动 股价大涨3.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617576780","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617576780?lang=zh_cn&edition=full","pubTime":"2026-03-05 10:10","pubTimestamp":1772676641,"startTime":"0","endTime":"0","summary":"2026年03月05日早盘10时10分，翰森制药股票出现异动，股价大幅上涨3.00%。截至发稿，该股报32.960港元/股，成交量143.116万股，换手率0.02%，振幅2.63%。资金方面，该股资金流入2428.18万港元，流出1386.16万港元。翰森制药股票所在的药品行业中，整体涨幅为1.21%。翰森制药公司简介：翰森制药集团有限公司是一家主要从事一系列药品的研发、生产及销售的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603051010419543110e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603051010419543110e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03692","BK1589","BK1583","BK1191"],"gpt_icon":0},{"id":"2616327622","title":"每日卖空追踪 | 翰森制药 03月03日卖空量成交68.8万股，卖空比例为8.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616327622","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616327622?lang=zh_cn&edition=full","pubTime":"2026-03-03 16:30","pubTimestamp":1772526637,"startTime":"0","endTime":"0","summary":"翰森制药北京时间03月03日，跌3.14%，卖空量成交68.8万股，较上一交易日减少70.75%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303163517a69cad42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303163517a69cad42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03692","BK1589","BK1191","BK1583"],"gpt_icon":0},{"id":"2616327982","title":"塔吉瑞创新药TGRX-678启动III期临床：攻克CML耐药“最后防线”，STAMP赛道迎新变局！","url":"https://stock-news.laohu8.com/highlight/detail?id=2616327982","media":"摩熵医药","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616327982?lang=zh_cn&edition=full","pubTime":"2026-03-03 15:34","pubTimestamp":1772523280,"startTime":"0","endTime":"0","summary":"塔吉瑞生物正式启动了其自主研发的TGRX-678片的首个III期临床试验。这意味着，塔吉瑞凭借TGRX-678的III期启动，至少在接下来的一段时间内，将独享“中国STAMP抑制剂领跑者”的光环，并有机会在国产替代与出海竞争中抢占先机。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303153457a69c6608&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303153457a69c6608&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","03692","06978","BK1191","BK1589","BK1583"],"gpt_icon":0},{"id":"2616276753","title":"翰森制药盘中异动 股价大跌3.26%报33.240港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616276753","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616276753?lang=zh_cn&edition=full","pubTime":"2026-03-03 10:20","pubTimestamp":1772504418,"startTime":"0","endTime":"0","summary":"2026年03月03日早盘10时20分，翰森制药股票出现异动，股价大幅下挫3.26%。截至发稿，该股报33.240港元/股，成交量188.526万股，换手率0.03%，振幅3.49%。资金方面，该股资金流入3328.7万港元，流出2433.58万港元。翰森制药股票所在的药品行业中，整体跌幅为0.64%。其相关个股中，精优药业、联康生物科技集团、培力农本方涨幅较大，振幅较大的相关个股有宝济药业-B、九源基因、英硅智能，振幅分别为13.59%、10.80%、7.34%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603031020189542b2b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603031020189542b2b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1589","03692","BK1583"],"gpt_icon":0},{"id":"1160311285","title":"翰森制药（03692）2月月报：股本维持不变，无新增发行或回购","url":"https://stock-news.laohu8.com/highlight/detail?id=1160311285","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160311285?lang=zh_cn&edition=full","pubTime":"2026-03-02 17:39","pubTimestamp":1772444360,"startTime":"0","endTime":"0","summary":"翰森制药集团有限公司于2026年3月2日发布截至2026年2月28日的证券变动月报表。报告显示，公司在本报告期内注册股本及已发行股本维持稳定，无新增发行、购回或库存股变动活动。截至2月底，已发行普通股股份总数依旧为6,055,150,070股，库存股份为零，无任何增减变动。公告确认公司现时已符合香港联交所对于最低公众持股量16.21%的相关要求。月报由联席公司秘书钟胜利女士签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692"],"gpt_icon":0},{"id":"2616712807","title":"瑞银：料医疗健康板块收入今年续增长10% 改列三生制药(01530)为首选","url":"https://stock-news.laohu8.com/highlight/detail?id=2616712807","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616712807?lang=zh_cn&edition=full","pubTime":"2026-03-02 13:46","pubTimestamp":1772430360,"startTime":"0","endTime":"0","summary":"瑞银改列三生制药为首选股，取代翰森制药，给予三生制药“买入”评级及目标价41港元，认为其估值合理。展望2026年，该行预测板块收入增长中位数为10%，看好创新药销售增长稳健及研发进展理想。该行并上调多只股份目标价，将石药集团目标价由10港元上调至10.9港元，翰森制药目标价由48.2港元上调至51.5港元，恒瑞医药目标价从96.9港元升至98.3港元，并分别给予“中性”、“买入”及“买入”评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1408878.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1226288170.HKD","LU1960683339.HKD","LABU","LU0326950275.SGD","LU1226287529.USD","LU1226288253.USD","LU2039709279.SGD","LU0501845795.SGD","LU0140636845.USD","BK1589","IE00BZ08YS42.EUR","LU1226287792.SGD","XBI","IE00B5MMRT66.SGD","01276","LU0359201612.USD","03692","LU1813983027.USD","BK4581","BK4588","HK0000165453.HKD","LU1023057109.AUD","LU0314109678.HKD","LU1152091168.USD","BK1521","IE00B031HY20.USD","IE0008369823.USD","IE00BZ08YR35.GBP","XLV","LU1328277881.USD","LU0880133367.SGD","LU1152091754.HKD","BK1161","IE00BZ08YT58.USD","BK1593","IE00B543WZ88.USD","LU2543165471.USD","LU0315179316.USD","LU1951186391.HKD","01530","SG9999004220.SGD","BK1583","BK4585","LU0359201885.HKD","159760","IE0008368742.USD","LU1226287875.USD","01093","LU0072913022.USD","BK1515"],"gpt_icon":0},{"id":"2616808044","title":"港股开盘受压 恒指低开1.22% 翰森制药(03692)跌3.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616808044","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616808044?lang=zh_cn&edition=full","pubTime":"2026-03-02 09:26","pubTimestamp":1772414819,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股开盘受压，恒指低开1.22%，国企指数低开1%，恒生科技指数低开1.78%。翰森制药跌3.89%，泡泡玛特跌3.39%，汇丰控股跌3.26%，中国人寿跌2.72%，银河娱乐跌2.59%。截至2月28日，公司累计汽车交付量达104.56万辆。百胜中国低开3.14%，公司发布公告，截至2025年12月31日止年度，系统销售额同比增长4%，不计及外币换算影响。截至2025年12月31日，门店总数达18,101家。经营利润率为10.9%，同比增长60个基点。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/YTI1MmE4Njc2MTkyMDEyMA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YTI1MmE4Njc2MTkyMDEyMA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1975670","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","PMRTY","601628","HHImain","03692","601899","00316","02833","MCHmain","600938","BK4588","HSBC","OROVY","ZIJMY","BK1589","00386","BK1191","600028","00005","NIO.SI","YUMC","09987","00857","513600","601857","02628","BK4585","00027"],"gpt_icon":1},{"id":"2614832325","title":"每日卖空追踪 | 翰森制药 02月27日卖空量成交118.4万股，卖空比例为9.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614832325","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614832325?lang=zh_cn&edition=full","pubTime":"2026-02-27 16:30","pubTimestamp":1772181036,"startTime":"0","endTime":"0","summary":"翰森制药北京时间02月27日，涨2.22%，卖空量成交118.4万股，较上一交易日减少47.8%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227163514a725f4eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227163514a725f4eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03692","BK1583","BK1191","BK1589"],"gpt_icon":0},{"id":"2614852088","title":"翰森制药02月27日获主力加仓220.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614852088","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614852088?lang=zh_cn&edition=full","pubTime":"2026-02-27 16:15","pubTimestamp":1772180131,"startTime":"0","endTime":"0","summary":"02月27日, 翰森制药股价涨2.22%，报收34.96元，成交金额4.1亿元，换手率0.20%，振幅3.45%，量比1.62。翰森制药今日主力资金净流入220.7万元，连续5日净流入，上一交易日主力净流入185.2万元。近一年数据显示，该股主力连续5日净流入后，次日上涨概率为46.15%，平均涨幅为2.12%。该股近5个交易日下跌4.74%，主力资金累计净流入2514.8万元；近20日主力资金累计净流入1.3亿元，其中净流入天数为16日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227161720a725e007&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227161720a725e007&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1583","03692","BK1589"],"gpt_icon":0},{"id":"2614832360","title":"翰森制药1类新药达麦利替尼申报上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2614832360","media":"医药时间","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614832360?lang=zh_cn&edition=full","pubTime":"2026-02-27 15:23","pubTimestamp":1772177017,"startTime":"0","endTime":"0","summary":"2月27日，中国国家药监局药品审评中心官网公示显示，翰森制药1类新药甲磺酸达麦利替尼片上市申请获得受理，具体适应症尚未披露。翰森制药此前在美国临床肿瘤学会年会上公布了HS-10241联合阿美替尼在既往经过治疗的EGFR突变晚期NSCLC患者中的1b期研究结果。在13例经中心实验室确认的EGFR敏感突变且MET扩增，缓解率61.5%，5例确认的PR，4例SD。药代动力学特征方面，HS-10241联合阿美替尼的潜在药物相互作用风险较低。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227154022a4ced162&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227154022a4ced162&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1589","03692","BK1191"],"gpt_icon":0},{"id":"2614078894","title":"每日卖空追踪 | 翰森制药 02月26日卖空量成交52.2万股，卖空比例为6.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614078894","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614078894?lang=zh_cn&edition=full","pubTime":"2026-02-26 16:30","pubTimestamp":1772094635,"startTime":"0","endTime":"0","summary":"翰森制药北京时间02月26日，跌1.16%，卖空量成交52.2万股，较上一交易日减少41.74%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226163524a7219c3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226163524a7219c3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1589","03692","BK1191","BK1583"],"gpt_icon":0},{"id":"2614722265","title":"每日卖空追踪 | 翰森制药 02月24日卖空量成交106.2万股，卖空比例为10.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614722265","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614722265?lang=zh_cn&edition=full","pubTime":"2026-02-24 16:30","pubTimestamp":1771921833,"startTime":"0","endTime":"0","summary":"翰森制药北京时间02月24日，跌6.43%，卖空量成交106.2万股，较上一交易日减少24.68%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224163539a7191d96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224163539a7191d96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1589","BK1583","03692"],"gpt_icon":0},{"id":"2614722215","title":"翰森制药肺癌新药阿美替尼欧盟获批上市！三代EGFR-TKI开启NSCLC治疗新篇","url":"https://stock-news.laohu8.com/highlight/detail?id=2614722215","media":"摩熵医药","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614722215?lang=zh_cn&edition=full","pubTime":"2026-02-24 16:22","pubTimestamp":1771921355,"startTime":"0","endTime":"0","summary":"2月20日，翰森制药宣布，创新药甲磺酸阿美替尼片单药治疗已正式获得欧盟委员会批准在欧盟上市，用于：具有表皮生长因子受体外显子19缺失或外显子21置换突变的晚期非小细胞肺癌成人患者的一线治疗；晚期EGFR T790M突变阳性NSCLC成人患者的治疗。作为翰森制药自主研发的三代EGFR-TKI，甲磺酸阿美替尼具有良好的脂溶性和稳定性，能更好地透过血脑屏障，且不良反应发生率低。该产品自2020年上市以来，持续深耕NSCLC治疗领域，不断拓展适应症边界。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224162242a4c228f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224162242a4c228f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1589","BK1191","03692"],"gpt_icon":0},{"id":"2613765081","title":"港股三大指数早盘集体受压 恒指半日跌1.93% 翰森制药跌6.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613765081","media":"金吾资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613765081?lang=zh_cn&edition=full","pubTime":"2026-02-24 12:16","pubTimestamp":1771906614,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股三大指数早盘集体受压，截至午间收盘，恒指跌1.93%，恒科指跌2.36%，国企指跌2.06%。建滔集团预期截至2025年12月31日止年度录得的纯利较2024年同期上升超过165%，即纯利超过43.2亿港元。截至2月16日，港股市场仍有401宗新股申请仍在处理之中，包括4家已通过聆讯的企业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224121707a4c1563b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224121707a4c1563b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00148","03692","BK4588","HSI","HSTECH","BK4614","BK4585","01888","KBDCY"],"gpt_icon":0},{"id":"2613122360","title":"大公司创新情报（2月21日）：翰森制药：甲磺酸阿美替尼片单药治疗于欧盟获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2613122360","media":"亿欧","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613122360?lang=zh_cn&edition=full","pubTime":"2026-02-21 17:37","pubTimestamp":1771666624,"startTime":"0","endTime":"0","summary":"今日看点翰森制药：甲磺酸阿美替尼片单药治疗于欧盟获批上市立讯精密港股IPO招股书失效今日情报翰森制药翰森制药：甲磺酸阿美替尼片单药治疗于欧盟获批上市立讯精密立讯精密港股IPO招股书失效回顾2月20日大公司创新情报，请点击 大公司创新情报：五粮液：公司暂无设立投资公司计划，资金以服务主业为核心大公司创新情报是亿欧数据推出的一款信息服务产品，为您网罗国内知名大公司的创新动态，持续追踪各领域的新技术新模式。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260221173952a70fe885&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260221173952a70fe885&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1589","03692","BK1583"],"gpt_icon":0},{"id":"2613422367","title":"翰森制药肺癌新药欧盟获批上市！","url":"https://stock-news.laohu8.com/highlight/detail?id=2613422367","media":"摩熵医药","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613422367?lang=zh_cn&edition=full","pubTime":"2026-02-21 12:51","pubTimestamp":1771649460,"startTime":"0","endTime":"0","summary":"2月20日，翰森制药宣布，创新药甲磺酸阿美替尼片单药治疗已正式获得欧盟委员会批准在欧盟上市，用于：具有表皮生长因子受体外显子19缺失或外显子21置换突变的晚期非小细胞肺癌成人患者的一线治疗；晚期EGFR T790M突变阳性NSCLC成人患者的治疗。作为翰森制药自主研发的三代EGFR-TKI，甲磺酸阿美替尼具有良好的脂溶性和稳定性，能更好地透过血脑屏障，且不良反应发生率低。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260221213027a7106237&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260221213027a7106237&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03692","BK1589","BK1191","BK1583"],"gpt_icon":0},{"id":"2612237504","title":"港股公告掘金 | 英硅智能、图达通及长风药业获纳入恒生综合指数成份股","url":"https://stock-news.laohu8.com/highlight/detail?id=2612237504","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612237504?lang=zh_cn&edition=full","pubTime":"2026-02-20 09:15","pubTimestamp":1771550100,"startTime":"0","endTime":"0","summary":"【重大事项】英硅智能(03696)获纳入恒生综合指数成份股图达通(02665)获纳入恒生综合指数成份股长风药业(02652)获纳入恒生综合指数成份股翰森制药(03692)：甲磺酸阿美替尼片单药治疗于欧盟获批上市拨康视云-B(02592)：CBT-199新药临床试验申请已生效，临床试验被认定为可安全推进石药集团(01093)：GLP -1/GIP受体双偏向性激动多肽长效注射液在美国获临床试验批准石药","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405958.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1191","03696","02652","02665","03692","VT","BK1144","HSCI","BK4585","VXUS","BK1179","BK1141","02498","BK1589","BK4588"],"gpt_icon":0},{"id":"2612231679","title":"翰森制药(03692)：甲磺酸阿美替尼片单药治疗于欧盟获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2612231679","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612231679?lang=zh_cn&edition=full","pubTime":"2026-02-20 07:01","pubTimestamp":1771542116,"startTime":"0","endTime":"0","summary":"智通财经APP讯，翰森制药(03692)公布，于2026年2月12日，集团创新药甲磺酸阿美替尼片(中国商品名：阿美乐®，海外商品名：Aumseqa®)单药治疗已于欧盟获批上市，用于：(i)具有表皮生长因子受体(EGFR)外显子19缺失或外显子21(L858R) 置换突变的晚期非小细胞肺癌(NSCLC)成人患者的一线治疗，以及(ii)晚期 EGFR T790M突变阳性NSCLC成人患者的治疗。此次批准由欧盟委员会(EC)基于欧洲药品管理局(EMA)人用药品委员会(CHMP)的积极意见作出。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405929.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1589","BK1583","FESXmain","BK1191","FSXEmain","03692"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0186},{"period":"1month","weight":-0.0757},{"period":"3month","weight":-0.1968},{"period":"6month","weight":-0.1202},{"period":"1year","weight":0.7722},{"period":"ytd","weight":-0.0654}],"compareEarnings":[{"period":"1week","weight":-0.025},{"period":"1month","weight":-0.0434},{"period":"3month","weight":-0.001},{"period":"6month","weight":-0.0302},{"period":"1year","weight":0.0486},{"period":"ytd","weight":-0.0087}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"翰森制药集团有限公司是一家主要从事一系列药品的研发、生产及销售的投资控股公司。该公司的创新药产品包括阿美乐、豪森昕福、迈灵达、孚来美、恒沐、昕越、圣罗莱等产品。该公司的创新药产品主要应用于抗肿瘤、抗感染、中枢神经系统（CNS）疾病、代谢及其他治疗领域。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":-0.002565},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.01282},{"month":3,"riseRate":0.285714,"avgChangeRate":0.016177},{"month":4,"riseRate":0.5,"avgChangeRate":0.03201},{"month":5,"riseRate":0.666667,"avgChangeRate":0.019349},{"month":6,"riseRate":0.666667,"avgChangeRate":0.055622},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.000332},{"month":8,"riseRate":0.714286,"avgChangeRate":0.01897},{"month":9,"riseRate":0.571429,"avgChangeRate":-0.033021},{"month":10,"riseRate":0.142857,"avgChangeRate":0.001586},{"month":11,"riseRate":0.714286,"avgChangeRate":0.063467},{"month":12,"riseRate":0.571429,"avgChangeRate":0.016858}],"exchange":"SEHK","name":"翰森制药","nameEN":"HANSOH PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"翰森制药(03692)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供翰森制药(03692)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"翰森制药,03692,翰森制药股票,翰森制药股票老虎,翰森制药股票老虎国际,翰森制药行情,翰森制药股票行情,翰森制药股价,翰森制药股市,翰森制药股票价格,翰森制药股票交易,翰森制药股票购买,翰森制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"翰森制药(03692)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供翰森制药(03692)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}